Traditional Chinese medicine Tongxie Yaofang treating irritable bowel syndrome with diarrhea and type 2 diabetes mellitus in rats with liver-depression and spleen-deficiency: A preliminary study.
Traditional Chinese medicine Tongxie Yaofang treating irritable bowel syndrome with diarrhea and type 2 diabetes mellitus in rats with liver-depression and spleen-deficiency: A preliminary study.
复制标题
中药痛泻要方治疗肝郁脾虚型肠易激综合征腹泻并2型糖尿病大鼠的初步研究
DOI:
10.3389/fnut.2022.968930
复制
发表时间:
2022
影响因子:
5
通讯作者:
Tao, Wenhua
中科院分区:
文献类型:
--
作者:
Xu, Weidong;Zhang, Zhiyi;Lu, Ye;Li, Mengxi;Li, Jiayao;Tao, Wenhua
Tongxie Yaofang (TXYF), a Traditional Chinese Medicine (TCM) with four components as follows: Rhizoma Atractylodis Macrocephalae (baizhu), Radix Paeoniae Alba (baishao), Pericarpium Citri Reticulatae (chenpi) and Radix Saposhnikovia Divaricata (fangfeng), benefits irritable bowel syndrome (IBS). Nonetheless, proofs of this formula ameliorating D-IBS and T2DM are required. This research aimed at investigating the efficacy of TXYF in treating inflammation in rats with D-IBS and T2DM using animal models. In this study, gavage with high-fat diet, fasciculation, and senna was given to develop rat models with target diseases. To determine intestinal inflammations, major inflammatory factors, and intestinal permeability proteins, H&E staining, ELISA, and immunohistochemistry methods were employed, respectively. This study also utilized Western blot to discover potential inflammatory targets. Results of this research illustrates that TXYF treatment reduced the level of TNF-α, IL-1β, and IL-6, and raised the IL-10 concentration in liver-depressed spleende ficient rats with D-IBS and T2DM, indicating controlled inflammatory reactions. Staining analysis also showed improved disease states of animal models. Furthermore, efficient rebounds of claudin-1, an intestinal permeability-associated protein, were detected. Moreover, TXYF may treat D-IBS and T2DM in rats via the rage pathway.
登录
查看更多内容
影响因子:
2.4
作者:
Bischoff SC;Barbara G;Buurman W;Ockhuizen T;Schulzke JD;Serino M;Tilg H;Watson A;Wells JM
通讯作者:
Wells JM
影响因子:
3.1
作者:
Gulcan, Erim;Taser, Figen;Alcelik, Aytekin
通讯作者:
Alcelik, Aytekin
影响因子:
--
作者:
Acharya AB;Thakur S;Muddapur MV
通讯作者:
Muddapur MV
影响因子:
8
作者:
Body-Malapel, M.;Djouina, M.;Vignal, C.
通讯作者:
Vignal, C.
影响因子:
6.6
作者:
Inai, T;Kobayashi, J;Shibata, Y
通讯作者:
Shibata, Y